Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E1 intracavernosal injection therapy to oral sildenafil citrate

F. Montorsi, S. E. Althof, M. Sweeney, F. Menchini-Fabris, F. Sasso, F. Giuliano

Research output: Contribution to journalArticle

Abstract

Treatment satisfaction, subanalysed by demographic variables, was evaluated in patients switching from successful intracavernosal prostaglandin E1 (PGE1) therapy to oral sildenafil citrate. The validated Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire was administered at the end of PGE1 therapy and after 12 weeks of sildenafil treatment in a multicentre, open-label study. Men with erectile dysfunction (n = 176) who were switched from stable PGE1 therapy to sildenafil (25-100 mg) were equally satisfied with onset of action, duration of action, and confidence in ability to engage in sexual activity, but expressed greater overall treatment satisfaction with sildenafil (P1 injection, these data suggest that patients may be less likely to discontinue taking sildenafil treatment for their erectile dysfunction.

Original languageEnglish
Pages (from-to)444-449
Number of pages6
JournalInternational Journal of Impotence Research
Volume15
Issue number6
DOIs
Publication statusPublished - Nov 2003

Fingerprint

Alprostadil
Erectile Dysfunction
Patient Satisfaction
Injections
Therapeutics
Aptitude
Sildenafil Citrate
Sexual Behavior
Demography
Equipment and Supplies

Keywords

  • Erectile dysfunction
  • Intracavernosal injection
  • Prostaglandin E1
  • Sildenafil

ASJC Scopus subject areas

  • Urology

Cite this

Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E1 intracavernosal injection therapy to oral sildenafil citrate. / Montorsi, F.; Althof, S. E.; Sweeney, M.; Menchini-Fabris, F.; Sasso, F.; Giuliano, F.

In: International Journal of Impotence Research, Vol. 15, No. 6, 11.2003, p. 444-449.

Research output: Contribution to journalArticle

@article{020c543311294bd189f9fe3d3eab6068,
title = "Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E1 intracavernosal injection therapy to oral sildenafil citrate",
abstract = "Treatment satisfaction, subanalysed by demographic variables, was evaluated in patients switching from successful intracavernosal prostaglandin E1 (PGE1) therapy to oral sildenafil citrate. The validated Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire was administered at the end of PGE1 therapy and after 12 weeks of sildenafil treatment in a multicentre, open-label study. Men with erectile dysfunction (n = 176) who were switched from stable PGE1 therapy to sildenafil (25-100 mg) were equally satisfied with onset of action, duration of action, and confidence in ability to engage in sexual activity, but expressed greater overall treatment satisfaction with sildenafil (P1 injection, these data suggest that patients may be less likely to discontinue taking sildenafil treatment for their erectile dysfunction.",
keywords = "Erectile dysfunction, Intracavernosal injection, Prostaglandin E1, Sildenafil",
author = "F. Montorsi and Althof, {S. E.} and M. Sweeney and F. Menchini-Fabris and F. Sasso and F. Giuliano",
year = "2003",
month = "11",
doi = "10.1038/sj.ijir.3901049",
language = "English",
volume = "15",
pages = "444--449",
journal = "International Journal of Impotence Research",
issn = "0955-9930",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E1 intracavernosal injection therapy to oral sildenafil citrate

AU - Montorsi, F.

AU - Althof, S. E.

AU - Sweeney, M.

AU - Menchini-Fabris, F.

AU - Sasso, F.

AU - Giuliano, F.

PY - 2003/11

Y1 - 2003/11

N2 - Treatment satisfaction, subanalysed by demographic variables, was evaluated in patients switching from successful intracavernosal prostaglandin E1 (PGE1) therapy to oral sildenafil citrate. The validated Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire was administered at the end of PGE1 therapy and after 12 weeks of sildenafil treatment in a multicentre, open-label study. Men with erectile dysfunction (n = 176) who were switched from stable PGE1 therapy to sildenafil (25-100 mg) were equally satisfied with onset of action, duration of action, and confidence in ability to engage in sexual activity, but expressed greater overall treatment satisfaction with sildenafil (P1 injection, these data suggest that patients may be less likely to discontinue taking sildenafil treatment for their erectile dysfunction.

AB - Treatment satisfaction, subanalysed by demographic variables, was evaluated in patients switching from successful intracavernosal prostaglandin E1 (PGE1) therapy to oral sildenafil citrate. The validated Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire was administered at the end of PGE1 therapy and after 12 weeks of sildenafil treatment in a multicentre, open-label study. Men with erectile dysfunction (n = 176) who were switched from stable PGE1 therapy to sildenafil (25-100 mg) were equally satisfied with onset of action, duration of action, and confidence in ability to engage in sexual activity, but expressed greater overall treatment satisfaction with sildenafil (P1 injection, these data suggest that patients may be less likely to discontinue taking sildenafil treatment for their erectile dysfunction.

KW - Erectile dysfunction

KW - Intracavernosal injection

KW - Prostaglandin E1

KW - Sildenafil

UR - http://www.scopus.com/inward/record.url?scp=0347763652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347763652&partnerID=8YFLogxK

U2 - 10.1038/sj.ijir.3901049

DO - 10.1038/sj.ijir.3901049

M3 - Article

C2 - 14671665

AN - SCOPUS:0347763652

VL - 15

SP - 444

EP - 449

JO - International Journal of Impotence Research

JF - International Journal of Impotence Research

SN - 0955-9930

IS - 6

ER -